JP2004527469A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004527469A5 JP2004527469A5 JP2002549711A JP2002549711A JP2004527469A5 JP 2004527469 A5 JP2004527469 A5 JP 2004527469A5 JP 2002549711 A JP2002549711 A JP 2002549711A JP 2002549711 A JP2002549711 A JP 2002549711A JP 2004527469 A5 JP2004527469 A5 JP 2004527469A5
- Authority
- JP
- Japan
- Prior art keywords
- endothelial cells
- substances
- tumor
- growth
- prevented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA2063/2000 | 2000-12-12 | ||
| AT20632000 | 2000-12-12 | ||
| PCT/AT2001/000387 WO2002048180A2 (de) | 2000-12-12 | 2001-12-07 | Peptide und/oder proteine sowie verwendung desselben zur herstellung eines therapeutischen und/oder präventiven arzneimittels |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2004527469A JP2004527469A (ja) | 2004-09-09 |
| JP2004527469A6 JP2004527469A6 (ja) | 2005-02-03 |
| JP2004527469A5 true JP2004527469A5 (enExample) | 2005-04-14 |
| JP4181874B2 JP4181874B2 (ja) | 2008-11-19 |
Family
ID=3689750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002549711A Expired - Fee Related JP4181874B2 (ja) | 2000-12-12 | 2001-12-07 | ペプチドおよび／またはタンパク質、並びにその治療用および／または予防用医薬成分を調製するための使用 |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US7271144B2 (enExample) |
| EP (2) | EP1341819B1 (enExample) |
| JP (1) | JP4181874B2 (enExample) |
| KR (1) | KR100864069B1 (enExample) |
| CN (2) | CN1518558B (enExample) |
| AT (2) | ATE329614T1 (enExample) |
| AU (1) | AU2002221316A1 (enExample) |
| BG (1) | BG107891A (enExample) |
| BR (1) | BR0116122A (enExample) |
| CA (1) | CA2430972C (enExample) |
| CY (2) | CY1106108T1 (enExample) |
| CZ (1) | CZ20031630A3 (enExample) |
| DE (2) | DE50114771D1 (enExample) |
| DK (2) | DK1586586T3 (enExample) |
| EA (1) | EA005576B1 (enExample) |
| EE (1) | EE200300283A (enExample) |
| ES (2) | ES2323963T3 (enExample) |
| HR (1) | HRP20030564A2 (enExample) |
| HU (1) | HUP0401536A3 (enExample) |
| IL (2) | IL156360A0 (enExample) |
| MX (1) | MXPA03005218A (enExample) |
| NO (1) | NO330767B1 (enExample) |
| NZ (1) | NZ550619A (enExample) |
| PL (2) | PL209419B1 (enExample) |
| PT (2) | PT1341819E (enExample) |
| SI (2) | SI1586586T1 (enExample) |
| SK (1) | SK7062003A3 (enExample) |
| WO (1) | WO2002048180A2 (enExample) |
| YU (1) | YU53803A (enExample) |
| ZA (1) | ZA200304545B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2430972C (en) | 2000-12-12 | 2014-08-05 | Fibrex Medical Research & Development Gmbh | Fibrin fragments for treating inflammation |
| WO2006000007A1 (de) * | 2004-06-25 | 2006-01-05 | Fibrex Medical Research & Development Gesmbh | Verwendung von peptiden, die aus der a alpha oder der b beta kette des humanen fibrinogens abgeleitet wurden, zur behandlung von schock |
| FR2879604B1 (fr) * | 2004-12-22 | 2010-08-13 | Biomerieux Sa | Peptides citrullines derives de la fibrine reconnus par des auto-anticorps specifiques de la polyarthrite rhumatoide, et leurs utilisations |
| AT502987A1 (de) | 2005-12-23 | 2007-07-15 | Fibrex Medical Res & Dev Gmbh | Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen |
| CN101389653A (zh) | 2006-02-23 | 2009-03-18 | 菲布雷克斯医疗研究及开发有限责任公司 | 肽和肽衍生物以及含有它们的药物组合物 |
| WO2007095659A1 (de) * | 2006-02-23 | 2007-08-30 | Fibrex Medical Research & Development Gmbh | Peptide und peptid-derivate, herstellun derselben sowie deren verwendung zur herstellung eines therapeutisch und/oder präventiv wirkenden arzneimittels |
| EP1987063B1 (en) * | 2006-02-23 | 2009-09-23 | Fibrex Medical Research & Development GmbH | Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| FR2900657B1 (fr) * | 2006-05-03 | 2009-04-17 | Univ Toulouse | Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide |
| WO2009038729A2 (en) | 2007-09-17 | 2009-03-26 | Regenerx Biopharmaceuticals, Inc. | Compositions and methods utilizing fibrin beta chain fragments of the bbeta chain of fibrinogen |
| FR2908134B1 (fr) * | 2007-12-04 | 2012-10-12 | Univ Toulouse 3 Paul Sabatier | Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide |
| WO2009096502A1 (ja) * | 2008-01-31 | 2009-08-06 | Japan As Represented By President Of National Center Of Neurology And Psychiatry | うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断 |
| US20090286725A1 (en) * | 2008-05-15 | 2009-11-19 | Fibrex Medical Research & Development Gmbh | Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| US8088890B2 (en) | 2008-09-26 | 2012-01-03 | Fibrex Medical Research & Development Gmbh | Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| WO2010043444A2 (en) * | 2008-10-15 | 2010-04-22 | Fibrex Medical Research & Development Gmbh | Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof |
| US20100152832A1 (en) * | 2008-12-12 | 2010-06-17 | Medtronic Vascular, Inc. | Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta |
| WO2013082458A1 (en) | 2011-12-02 | 2013-06-06 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
| US12171802B2 (en) | 2016-06-02 | 2024-12-24 | University Of Maryland, Baltimore | Compositions for inhibiting fibrin-VLDL receptor-dependent inflammation and methods of treatment |
| EP3912679A1 (en) * | 2020-05-19 | 2021-11-24 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Bbeta-15-42 for the treatment of viral endothelitis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4927916A (en) * | 1984-04-23 | 1990-05-22 | The General Hospital Corporation | Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides |
| US5965107A (en) * | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
| DE19729591A1 (de) * | 1997-07-10 | 1999-02-11 | Therasorb Medizinische Systeme | Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen |
| FR2795735B1 (fr) * | 1999-07-01 | 2001-09-07 | Univ Toulouse | Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide |
| CA2430972C (en) * | 2000-12-12 | 2014-08-05 | Fibrex Medical Research & Development Gmbh | Fibrin fragments for treating inflammation |
| US7201763B2 (en) * | 2001-10-24 | 2007-04-10 | Boston Scientific Scimed, Inc. | Distal balloon waist material relief and method of manufacture |
-
2001
- 2001-12-07 CA CA2430972A patent/CA2430972C/en not_active Expired - Fee Related
- 2001-12-07 CN CN018225993A patent/CN1518558B/zh not_active Expired - Fee Related
- 2001-12-07 YU YU53803A patent/YU53803A/sh unknown
- 2001-12-07 DE DE50114771T patent/DE50114771D1/de not_active Expired - Lifetime
- 2001-12-07 ES ES05012488T patent/ES2323963T3/es not_active Expired - Lifetime
- 2001-12-07 MX MXPA03005218A patent/MXPA03005218A/es active IP Right Grant
- 2001-12-07 PT PT01270546T patent/PT1341819E/pt unknown
- 2001-12-07 DK DK05012488T patent/DK1586586T3/da active
- 2001-12-07 CN CN200910163553A patent/CN101676299A/zh active Pending
- 2001-12-07 AT AT01270546T patent/ATE329614T1/de active
- 2001-12-07 IL IL15636001A patent/IL156360A0/xx unknown
- 2001-12-07 AU AU2002221316A patent/AU2002221316A1/en not_active Abandoned
- 2001-12-07 SI SI200130917T patent/SI1586586T1/sl unknown
- 2001-12-07 PL PL362924A patent/PL209419B1/pl not_active IP Right Cessation
- 2001-12-07 DK DK01270546T patent/DK1341819T3/da active
- 2001-12-07 HU HU0401536A patent/HUP0401536A3/hu unknown
- 2001-12-07 CZ CZ20031630A patent/CZ20031630A3/cs unknown
- 2001-12-07 ES ES01270546T patent/ES2266093T3/es not_active Expired - Lifetime
- 2001-12-07 SI SI200130609T patent/SI1341819T1/sl unknown
- 2001-12-07 PL PL390342A patent/PL209752B1/pl not_active IP Right Cessation
- 2001-12-07 PT PT05012488T patent/PT1586586E/pt unknown
- 2001-12-07 EA EA200300678A patent/EA005576B1/ru not_active IP Right Cessation
- 2001-12-07 HR HR20030564A patent/HRP20030564A2/hr not_active Application Discontinuation
- 2001-12-07 AT AT05012488T patent/ATE425184T1/de active
- 2001-12-07 EP EP01270546A patent/EP1341819B1/de not_active Expired - Lifetime
- 2001-12-07 NZ NZ550619A patent/NZ550619A/en unknown
- 2001-12-07 EE EEP200300283A patent/EE200300283A/xx unknown
- 2001-12-07 BR BR0116122-9A patent/BR0116122A/pt not_active Application Discontinuation
- 2001-12-07 DE DE50110182T patent/DE50110182D1/de not_active Expired - Lifetime
- 2001-12-07 JP JP2002549711A patent/JP4181874B2/ja not_active Expired - Fee Related
- 2001-12-07 KR KR1020037007799A patent/KR100864069B1/ko not_active Expired - Fee Related
- 2001-12-07 WO PCT/AT2001/000387 patent/WO2002048180A2/de not_active Ceased
- 2001-12-07 EP EP05012488A patent/EP1586586B1/de not_active Expired - Lifetime
- 2001-12-07 SK SK706-2003A patent/SK7062003A3/sk unknown
-
2003
- 2003-06-09 IL IL156360A patent/IL156360A/en not_active IP Right Cessation
- 2003-06-09 BG BG107891A patent/BG107891A/bg unknown
- 2003-06-11 US US10/459,030 patent/US7271144B2/en not_active Expired - Fee Related
- 2003-06-12 NO NO20032656A patent/NO330767B1/no not_active IP Right Cessation
-
2004
- 2004-06-11 ZA ZA200304545A patent/ZA200304545B/en unknown
-
2006
- 2006-06-27 CY CY20061100876T patent/CY1106108T1/el unknown
- 2006-10-03 US US11/542,050 patent/US7494973B2/en not_active Expired - Lifetime
-
2007
- 2007-09-06 US US11/899,611 patent/US7811985B2/en not_active Expired - Fee Related
-
2008
- 2008-10-09 US US12/248,656 patent/US8067373B2/en not_active Expired - Fee Related
-
2009
- 2009-05-29 CY CY20091100574T patent/CY1109107T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004527469A5 (enExample) | ||
| Kovanecz et al. | Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats | |
| Ferrannini et al. | Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes | |
| Pather et al. | Current status and the future of buccal drug delivery systems | |
| EP1163902A3 (en) | Transdermal preparation containing hydrophilic or salt-form drug | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| MD20070267A (en) | Gastroresistant pharmaceutical formulation containing rifaximin | |
| BR9914360A (pt) | N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5 | |
| EP1233756A4 (en) | SOLID EXCIPIENTS FOR IMPROVED ADMINISTRATION OF ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS | |
| JP2008519047A5 (enExample) | ||
| CY1112738T1 (el) | Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη | |
| EA200602137A1 (ru) | Гидрогелевые препараты интерферона | |
| ATE396967T1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
| WO2009106819A3 (en) | Biological materials and uses thereof | |
| CY1112184T1 (el) | Πυριδοξαμινη για χρηση στην αγωγη της διαβητικης nεφροπαθειας στο διαβητη τυπου ii | |
| EA200602047A1 (ru) | Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака | |
| EA200600468A1 (ru) | Биполярные транс-каротиноидные соли и их применение | |
| Prajapati et al. | Lipid-based nanoformulations in onychomycosis therapy: addressing challenges of current therapies and advancing treatment | |
| NO20055209D0 (no) | Peptabody for cancerbehandling | |
| JP2004002429A5 (enExample) | ||
| JP2014534229A5 (enExample) | ||
| Peura et al. | Sustained release of metformin via red blood cell accumulated sulfenamide prodrug | |
| RU2006131553A (ru) | Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap | |
| WO2006133194A3 (en) | Methods for treating viral infection with oral or injectible drug solution | |
| ATE228843T1 (de) | Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit |